Clinical trials
30 active studies led by Aesculap AG, of 110 in all
Source: ClinicalTrials.gov, Studies with Aesculap AG (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 5Markets in public records
- 0Regions & countries
- 30Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Aesculap AG or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Aesculap AG
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- aesculap.de
- Home country
- Germany
Source: Wikidata, Company record Q44092. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
42 510(k) clearances and PMA approvals since 2015
- Ventricular Catheters, Thomale Catheter K260044 · 2 Oct 2026
- Aesculap Aicon® Series Container System K242762 · 13 May 2025
- Xabo Ventricular Catheter, Xabo Peritoneal Catheter, Xabo Catheter Set K242003 · 16 Dec 2024
- Sq.line Kerrison K223596 · 29 Jun 2023
- Aesculap Aicon Container K214041 · 30 Dec 2022
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
US recalls
26 recalls since 2015 (26 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Trials over time
Studies Aesculap AG leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Aesculap AG or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Aesculap AG: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Aesculap AG is in.
From our blog
Stories on the topics Aesculap AG works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D: Deficiency, Testing and Supplements
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read